Trial Outcomes & Findings for Feasibility and Preliminary Efficacy of an Opioid Stewardship Program in Hospitalized Patients With Chronic Pain (NCT NCT05370326)
NCT ID: NCT05370326
Last Updated: 2024-03-05
Results Overview
Feasibility of recruitment will be determined by a count of the number of participants screened for the study compared to number of eligible participants.
COMPLETED
NA
52 participants
approximately 3 months
2024-03-05
Participant Flow
Participant milestones
| Measure |
Enhanced Opioid Stewardship Program
Enhanced opioid stewardship program, tailored to the needs of hospitalized patients with chronic pain with opioid dependence, incorporating real-time guidance from an addiction medicine and pain-trained physician/pharmacist team
Enhanced Opioid Stewardship Program: The goal of the enhanced opioid stewardship intervention is to manage chronic pain while reducing risk of inappropriate/risky opioid use and preventing harms of opioid use.
|
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Overall Study
STARTED
|
36
|
16
|
|
Overall Study
Complete Clinical Data
|
36
|
16
|
|
Overall Study
Complete Self Report Data
|
31
|
14
|
|
Overall Study
COMPLETED
|
36
|
16
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Feasibility and Preliminary Efficacy of an Opioid Stewardship Program in Hospitalized Patients With Chronic Pain
Baseline characteristics by cohort
| Measure |
Enhanced Opioid Stewardship Program
n=36 Participants
Enhanced opioid stewardship program, tailored to the needs of hospitalized patients with chronic pain with opioid dependence, incorporating real-time guidance from an addiction medicine and pain-trained physician/pharmacist team
Enhanced Opioid Stewardship Program: The goal of the enhanced opioid stewardship intervention is to manage chronic pain while reducing risk of inappropriate/risky opioid use and preventing harms of opioid use.
|
Standard of Care
n=16 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
|
Total
n=52 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
55.1 years
STANDARD_DEVIATION 13.7 • n=5 Participants
|
52.3 years
STANDARD_DEVIATION 15.0 • n=7 Participants
|
53.7 years
STANDARD_DEVIATION 14.0 • n=5 Participants
|
|
Sex: Female, Male
Female
|
18 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
28 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
18 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
24 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
31 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
41 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
15 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
20 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
36 participants
n=5 Participants
|
16 participants
n=7 Participants
|
52 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: approximately 3 monthsPopulation: All participants that were screened for eligibility
Feasibility of recruitment will be determined by a count of the number of participants screened for the study compared to number of eligible participants.
Outcome measures
| Measure |
Total Participants Screened
n=510 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Number of Participants Screened Compared to Number of Eligible Participants to Determine Feasibility of Recruitment
Eligible participants approached
|
97 Participants
|
—
|
|
Number of Participants Screened Compared to Number of Eligible Participants to Determine Feasibility of Recruitment
Ineligible participants due to Inclusion
|
62 Participants
|
—
|
|
Number of Participants Screened Compared to Number of Eligible Participants to Determine Feasibility of Recruitment
Ineligible participants due to Exclusion
|
351 Participants
|
—
|
PRIMARY outcome
Timeframe: approximately 3 monthsPopulation: Total number of eligible participants.
Feasibility of recruitment will be determined by a count of the number of participants eligible for the study compared to number of enrolled participants.
Outcome measures
| Measure |
Total Participants Screened
n=97 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Number of Eligible Participants Compared to Number of Enrolled Participants to Determine Feasibility of Recruitment
Declined to hear about study
|
22 Participants
|
—
|
|
Number of Eligible Participants Compared to Number of Enrolled Participants to Determine Feasibility of Recruitment
Agreed to hear about study: Consented
|
52 Participants
|
—
|
|
Number of Eligible Participants Compared to Number of Enrolled Participants to Determine Feasibility of Recruitment
Agreed to hear about study: Did not consent
|
23 Participants
|
—
|
PRIMARY outcome
Timeframe: approximately 3 monthsDays to hospital day of enrollment in relation to admission and discharge dates
Outcome measures
| Measure |
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
n=16 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Days to Hospital Day of Enrollment
|
9.66 days
Standard Error 1.12
|
10.56 days
Standard Error 2.30
|
PRIMARY outcome
Timeframe: approximately 3 monthsPopulation: Only participants in the intervention.
Number of participants in the intervention group who were able to receive the full enhanced opioid stewardship intervention to determine retention
Outcome measures
| Measure |
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Number of Participants in the Intervention Group Who Were Able to Receive the Full Enhanced Opioid Stewardship Intervention
|
36 Participants
|
—
|
PRIMARY outcome
Timeframe: approximately 3 monthsPopulation: Only participants in the intervention.
Number of participants in the intervention group who were able to complete the peri-discharge evaluation to determine retention.
Outcome measures
| Measure |
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Number of Participants in Intervention Group Who Complete the Peri-discharge Evaluation.
Clinical outcomes provided
|
36 Participants
|
—
|
|
Number of Participants in Intervention Group Who Complete the Peri-discharge Evaluation.
Self reported outcomes provided
|
31 Participants
|
—
|
PRIMARY outcome
Timeframe: approximately 3 monthsPopulation: Only participants in the control group.
Number of participants in the control group who were able to complete the peri-discharge evaluation to determine retention.
Outcome measures
| Measure |
Total Participants Screened
n=16 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Number of Participants in Control Group Who Complete the Peri-discharge Evaluation.
Clinical outcomes provided
|
16 Participants
|
—
|
|
Number of Participants in Control Group Who Complete the Peri-discharge Evaluation.
Self-reported outcomes provided
|
14 Participants
|
—
|
SECONDARY outcome
Timeframe: approximately 4 monthsPopulation: Only those in Enhanced Opioid Stewardship Program
A a count of guideline-based care elements considered to be "best practices" for opioid stewardship in the setting of chronic pain will be collected during hospitalizations. These include ordering of alternative pain relief medications (e.g., acetaminophen), ordering of a bowel regimen, ordering of medication to treat opioid use disorder, order of urine toxicology screen, ordering of ECG for patients prescribed methadone, avoidance of co-prescriptions of benzodiazepines, and other associate "best care" practices. These metrics will be abstracted from the medical record. The number is out of a possible 12 recommendations- 12 would be the most recommendations a participant could have received.
Outcome measures
| Measure |
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Number of Guideline-based Care Elements in Use Considered Guideline Concordant Care With Opioids for Pain During Hospitalization.
|
4.4 Physician guideline-concordant recommend
Interval 2.0 to 8.0
|
—
|
SECONDARY outcome
Timeframe: Baseline and 48 hours prior to discharge from hospitalPopulation: Participants with complete data
The Brief Pain Inventory measures the intensity of pain, along with the degree to which the pain interferes with the everyday functioning of life. Scores range from 0 (no pain) to 10 (severe pain).
Outcome measures
| Measure |
Total Participants Screened
n=30 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
n=14 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Change in Pain Intensity Measured by the Brief Pain Inventory - Severity
|
-0.46 score on a scale
Standard Error 0.26
|
-0.23 score on a scale
Standard Error 0.59
|
SECONDARY outcome
Timeframe: Baseline and 48 hours prior to discharge from hospitalPopulation: Participants with complete data
The Brief Pain Inventory measures the intensity of pain, along with the degree to which the pain interferes with the everyday functioning of life. Scores range from 0 (no life interference) to 10 (complete interference).
Outcome measures
| Measure |
Total Participants Screened
n=30 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
n=14 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Change in Pain Intensity Measured by the Brief Pain Inventory - Interference
|
-1.21 score on a scale
Standard Error 0.50
|
-0.62 score on a scale
Standard Error 0.64
|
SECONDARY outcome
Timeframe: Baseline and 48 hours prior to discharge from hospitalPopulation: Participants with complete data.
The Patient Health Questionnaire measures Change in depression. Scores range from 0 (no depression) to 27 (severe depression).
Outcome measures
| Measure |
Total Participants Screened
n=30 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
n=14 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Change in Depression Measured by the Patient Health Questionnaire
|
-0.56 score on a scale
Standard Error 0.38
|
-0.35 score on a scale
Standard Error 0.43
|
SECONDARY outcome
Timeframe: 48 hours prior to discharge from hospitalPopulation: These data were not collected.
Patient satisfaction will be measured using a Likert scale with scores ranging from a scale of 1-5 (1 not satisfied, 5 very satisfied). These data were not collected as part of the completed study.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: up to 30 days post hospitalizationPopulation: All participants
The Number of participants with hospital re-admissions at 30 days after hospitalization. Outcome was updated upon results entry.
Outcome measures
| Measure |
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
n=16 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Count of Participants With Hospital Re-admissions at 30 Days After Hospitalization
Readmission in 30 days: Yes
|
14 Participants
|
4 Participants
|
|
Count of Participants With Hospital Re-admissions at 30 Days After Hospitalization
Readmission in 30 days: No
|
22 Participants
|
12 Participants
|
SECONDARY outcome
Timeframe: up to 30 days post hospitalizationPopulation: All participants
The count of participants with emergency department visits at 30 days after hospitalization. The outcome was updated when results were entered.
Outcome measures
| Measure |
Total Participants Screened
n=36 Participants
This is the total number of participants that were screened for eligibility.
|
Standard of Care
n=16 Participants
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Count of Participants With Emergency Department Visit(s) at 30 Days After Hospitalization
ED Visit within 30 Days: Yes
|
15 Participants
|
5 Participants
|
|
Count of Participants With Emergency Department Visit(s) at 30 Days After Hospitalization
ED Visit within 30 Days: No
|
21 Participants
|
11 Participants
|
Adverse Events
Enhanced Opioid Stewardship Program
Standard of Care
Serious adverse events
| Measure |
Enhanced Opioid Stewardship Program
n=36 participants at risk
Enhanced opioid stewardship program, tailored to the needs of hospitalized patients with chronic pain with opioid dependence, incorporating real-time guidance from an addiction medicine and pain-trained physician/pharmacist team
Enhanced Opioid Stewardship Program: The goal of the enhanced opioid stewardship intervention is to manage chronic pain while reducing risk of inappropriate/risky opioid use and preventing harms of opioid use.
|
Standard of Care
n=16 participants at risk
Participants received standard of care services without the enhanced opioid stewardship program.
|
|---|---|---|
|
Cardiac disorders
Cardiorespiratory arrest
|
2.8%
1/36 • Number of events 1 • Up to 4 months
|
0.00%
0/16 • Up to 4 months
|
Other adverse events
Adverse event data not reported
Additional Information
Melissa B. Weimer, DO, MCR, DFASAM
Yale School of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place